New Promise in Preventing Cervical Cancer
Human papilloma virus (HPV) has long been known to be a primary cause of cervical cancer. Scientists have discovered that an existing drug can put the body's natural defense system into action to kill this virus before cancer develops.
Second-Hand Smoke Does It Again
Past studies have shown that women smokers have a higher risk of cervical cancer. Now, new research shows that second-hand smoke may damage cells in a woman's cervix, increasing her risk of cervical cancer.
A study funded by HPV (human papillomavirus) vaccine maker, Merck & Co., finds the HPV vaccine Gardasil® protects boys as well as girls against the virus.
Immigrant Women Less Likely to Have Cervical Cancer Screenings
Canadian immigrant women are screened less often for cervical cancer than native-born Canadian women, according to a new study from St. Michael's Hospital.
Ceasing Cervical Cancer
GlaxoSmithKline has granted an unrestricted gift to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation, to focus research efforts on cervical-cancer prevention.
Hardly a Shot in the Dark
A study from the University of Maryland has found that few eligible young women choose to take the HPV (human papillomavirus) vaccine, and, of those who do, relatively few take the recommended three doses. HPV is a known cause of cervical cancer.